Osmotica Pharmaceuticals plc (NASDAQ:OSMT) changed -5.27% to recent value of $5.12. The stock transacted 368347 shares during last trading day however it has an average volume of 185.69K shares. It spotted trading -45.26% off 52-week high price. On the other end, the stock has been noted 132.73% away from the low price over the last 52-weeks.
On Jan. 8, 2020, Osmotica Pharmaceuticals plc (NASDAQ:OSMT) a fully integrated biopharmaceutical company, disclosed the pricing of its public offering of 6,000,000 ordinary shares at a price to the public of $5.00 per share. All of the shares will be offered by Osmotica. In addition, Osmotica has granted the underwriters a 30-day option to purchase up to an additional 900,000 ordinary shares at the public offering price less underwriting discounts and commissions. The offering is expected to close on January 13, 2020, subject to customary closing conditions.
About Osmotica Pharmaceuticals plc
Osmotica Pharmaceuticals plc is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations. Vertical Pharmaceuticals, LLC represents the Company’s diversified branded portfolio and Trigen Laboratories, LLC represents the non-promoted products including complex generic formulations.
OSMT has a gross margin of 49.10%. Its earnings per share (EPS) expected to touch remained -151.70% for this year.
The company has 51.89M of outstanding shares and 6.74M shares were floated in the market. According to the most recent quarter its current ratio was 2.1 that represents company’s ability to meet its current financial obligations. The price moved ahead of -26.83% from the mean of 20 days, -12.23% from mean of 50 days SMA and performed 24.87% from mean of 200 days price. Company’s performance for the week was -26.75%, -21.35% for month and YTD performance remained -26.75%.